Join my project! A pitch session for radiation therapist-led research

Sunday

May 04

11:40 - 12:45

Plenary Hall

Joint Green Journal - The Lancet Oncology: Top Clinical Trials

Chair: David Collingridge, United Kingdom;

Chair: Pierre Blanchard, France

Overview: This session will celebrate the best abstract submitted to each track. Join us in congratulating the winners during this plenary session and listen to the top-level presentations.

Session Type: Proffered Papers

Track: Interdisciplinary

Journey: Dosimetry & QA / GI / SBRT

11:40 - 11:49

PLATO ACT 4: Long term results of an RCT evaluating reduced dose and standard dose chemoradiotherapy in early-stage anal cancer (ISRCTN:88455282)

Presenter: David Sebag-Montefore, United Kingdom

Presentation Number: E25-3665

11:49 - 11:58

STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer

Presenter: , The Netherlands

Presentation Number: E25-1489

11:58 - 12:06

Discussant

Discussant: , Italy

12:06 - 12:15

PRIME-RT: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC): a randomised phase II trial

Presenter: Campbell Roxburgh, United Kingdom

Presentation Number: E25-1116

12:15 - 12:24

Short-term radiotherapy plus chemotherapy for locally advanced rectal cancer: 5-year outcomes of the phase III clinical trial (NCT02533271)

Presenter: Yuan Tang, China

Presentation Number: E25-2250

12:24 - 12:33

Preoperative Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer: Phase II Results of STELLAR II

Presenter: Jing Jin, China

Presentation Number: E25-837

12:33 - 12:45

Discussant

Discussant: Claus Rödel, Germany

ESTRO 2025

Session